Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation

Table 2

UPLC-HRMS gradient programme for analysis of simulation samples.

Time (minutes)	Mobile phase A (%)	Mobile phase B (%)
0	100	0
2.78	97	3
6.95	80	20
9.73	65	35
12.5	60	40
12.78	100	0
14.00	100	0